These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 24090798)

  • 1. Topical combination of diclofenac, calcipotriol, and difluoromethylornithine has beneficial effects comparable to 5-fluorouracil for the treatment of non-melanoma skin cancer in mice.
    Pommergaard HC; Burcharth J; Rosenberg J; Raskov H
    J Chemother; 2014 Apr; 26(2):105-10. PubMed ID: 24090798
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combination chemoprevention with diclofenac, calcipotriol and difluoromethylornithine inhibits development of non-melanoma skin cancer in mice.
    Pommergaard HC; Burcharth J; Rosenberg J; Raskov H
    Anticancer Res; 2013 Aug; 33(8):3033-9. PubMed ID: 23898057
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Topical treatment with diclofenac, calcipotriol (vitamin-D3 analog) and difluoromethylornithine (DFMO) does not prevent nonmelanoma skin cancer in mice.
    Pommergaard HC; Burcharth J; Rosenberg J; Raskov H
    Cancer Invest; 2013 Feb; 31(2):92-6. PubMed ID: 23362949
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phase IIB Randomized Study of Topical Difluoromethylornithine and Topical Diclofenac on Sun-Damaged Skin of the Forearm.
    Jeter JM; Curiel-Lewandrowski C; Stratton SP; Myrdal PB; Warneke JA; Einspahr JG; Bartels HG; Yozwiak M; Bermudez Y; Hu C; Bartels P; Alberts DS
    Cancer Prev Res (Phila); 2016 Feb; 9(2):128-34. PubMed ID: 26712942
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Basic pharmacology of topical imiquimod, 5-fluorouracil, and diclofenac for the dermatologic surgeon.
    Desai T; Chen CL; Desai A; Kirby W
    Dermatol Surg; 2012 Jan; 38(1):97-103. PubMed ID: 22092926
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Randomized trial of calcipotriol combined with 5-fluorouracil for skin cancer precursor immunotherapy.
    Cunningham TJ; Tabacchi M; Eliane JP; Tuchayi SM; Manivasagam S; Mirzaalian H; Turkoz A; Kopan R; Schaffer A; Saavedra AP; Wallendorf M; Cornelius LA; Demehri S
    J Clin Invest; 2017 Jan; 127(1):106-116. PubMed ID: 27869649
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment with 5-fluorouracil and celecoxib displays synergistic regression of ultraviolet light B-induced skin tumors.
    Wilgus TA; Breza TS; Tober KL; Oberyszyn TM
    J Invest Dermatol; 2004 Jun; 122(6):1488-94. PubMed ID: 15175041
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Topical hydrocortisone, clobetasol propionate, and calcipotriol do not increase photocarcinogenesis induced by simulated solar irradiation in hairless mice.
    Lerche CM; Philipsen PA; Poulsen T; Wulf HC
    Exp Dermatol; 2010 Nov; 19(11):973-9. PubMed ID: 20113348
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phase III randomized study of postradiotherapy chemotherapy with alpha-difluoromethylornithine-procarbazine, N-(2-chloroethyl)-N'-cyclohexyl-N-nitrosurea, vincristine (DFMO-PCV) versus PCV for glioblastoma multiforme.
    Levin VA; Uhm JH; Jaeckle KA; Choucair A; Flynn PJ; Yung WKA ; Prados MD; Bruner JM; Chang SM; Kyritsis AP; Gleason MJ; Hess KR
    Clin Cancer Res; 2000 Oct; 6(10):3878-84. PubMed ID: 11051233
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Skin cancer precursor immunotherapy for squamous cell carcinoma prevention.
    Rosenberg AR; Tabacchi M; Ngo KH; Wallendorf M; Rosman IS; Cornelius LA; Demehri S
    JCI Insight; 2019 Mar; 4(6):. PubMed ID: 30895944
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Medical approaches to non-melanoma skin cancer.
    Micali G; Lacarrubba F; Bhatt K; Nasca MR
    Expert Rev Anticancer Ther; 2013 Dec; 13(12):1409-21. PubMed ID: 24236820
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Taking treatment decisions in non-melanoma skin cancer--the place for topical photodynamic therapy (PDT).
    Sidoroff A; Thaler P
    Photodiagnosis Photodyn Ther; 2010 Mar; 7(1):24-32. PubMed ID: 20230990
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low-dose 5-fluorouracil in combination with salicylic acid as a new lesion-directed option to treat topically actinic keratoses: histological and clinical study results.
    Stockfleth E; Kerl H; Zwingers T; Willers C
    Br J Dermatol; 2011 Nov; 165(5):1101-8. PubMed ID: 21517801
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Anticancer treatment with a combination of antimetabolites of polyamine and pyrimidine].
    Fujimoto S; Shrestha RD; Igarashi K; Miyazaki M; Endoh F; Shimura T; Sugasawa H; Takahashi O; Kawata S; Ohta M
    Gan To Kagaku Ryoho; 1985 Oct; 12(10):2024-9. PubMed ID: 2932057
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevention of UVB-induced skin inflammation, genotoxicity, and photocarcinogenesis in mice by WHI-P131, a dual-function inhibitor of Janus kinase 3 and EGF receptor kinase.
    Uckun FM; Dibirdik I; Qazi S
    Arzneimittelforschung; 2010; 60(4):218-25. PubMed ID: 20486473
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phase III randomized study of postradiotherapy chemotherapy with combination alpha-difluoromethylornithine-PCV versus PCV for anaplastic gliomas.
    Levin VA; Hess KR; Choucair A; Flynn PJ; Jaeckle KA; Kyritsis AP; Yung WK; Prados MD; Bruner JM; Ictech S; Gleason MJ; Kim HW
    Clin Cancer Res; 2003 Mar; 9(3):981-90. PubMed ID: 12631596
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Time and dose-response effects of honokiol on UVB-induced skin cancer development.
    Guillermo RF; Chilampalli C; Zhang X; Zeman D; Fahmy H; Dwivedi C
    Drug Discov Ther; 2012 Jun; 6(3):140-6. PubMed ID: 22890204
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation of biologic endpoints by topical difluoromethylornithine (DFMO), in subjects at high-risk for nonmelanoma skin cancer.
    Einspahr JG; Nelson MA; Saboda K; Warneke J; Bowden GT; Alberts DS
    Clin Cancer Res; 2002 Jan; 8(1):149-55. PubMed ID: 11801552
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibitory effects of sodium salicylate and acetylsalicylic acid on UVB-induced mouse skin carcinogenesis.
    Bair WB; Hart N; Einspahr J; Liu G; Dong Z; Alberts D; Bowden GT
    Cancer Epidemiol Biomarkers Prev; 2002 Dec; 11(12):1645-52. PubMed ID: 12496056
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Total body topical 5-fluorouracil for extensive non-melanoma skin cancer.
    van Ruth S; Jansman FG; Sanders CJ
    Pharm World Sci; 2006 Jun; 28(3):159-62. PubMed ID: 17004017
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.